Q4-FY26 · Q3 FY26
EBITDA margins to remain at 12-13% through FY27
Current-quarter results and commentary indicate the prior promise was delivered or materially on track.
met
heuristic_v1
ROSSARIBIOTECH / Q4-FY26 / promises
Measure what management said.
Rossari Biotech · A quarter-by-quarter view of forward statements and whether delivery is visible yet.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Management delivery ledger
Promises over time.
Q4-FY26 · Q3 FY26
Capacity utilization ramp-up over 2+ years
Current-quarter results and commentary indicate the prior promise was delivered or materially on track.
met
heuristic_v1
Q4-FY26 · Q3 FY26
Core B2B margins targeted at 15%+
Current-quarter results and commentary indicate the prior promise was delivered or materially on track.
met
heuristic_v1